Literature DB >> 20665857

Transcatheter closure of the left atrial appendage: initial experience with the Amplatzer cardiac plug device.

Josep Rodés-Cabau1, Jean Champagne, Mathieu Bernier.   

Abstract

Percutaneous left atrial appendage (LAA) closure might reduce the cardioembolic risk in those patients with nonvalvular atrial fibrillation who are not candidates for warfarin therapy. This report presents the case of two patients with atrial fibrillation who had contraindications for warfarin therapy due to bleeding complications and a high cardioembolic risk (CHADS2 > or =2) who underwent successful LAA closure with a new device, the Amplatzer Cardiac Plug. The characteristics of the device and the main technical aspects of the procedure, as well as the potential advantages of this device for LAA closure, are discussed. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20665857     DOI： 10.1002/ccd.22499

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


  8 in total

1.  Percutaneous closure of left atrial appendage: device-indicated antiplatelet therapy may also lead to fatal bleeding. A call for evidence-based antiplatelet regimen.

Authors:  Juan Ruiz-García; Raúl Moreno
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

Review 2.  Left atrial appendage exclusion for prevention of stroke in atrial fibrillation: review of minimally invasive approaches.

Authors:  Joshua D Moss
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

3.  Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.

Authors:  Steffen Gloekler; Samera Shakir; Janosch Doblies; Ahmed A Khattab; Fabien Praz; Ênio Guerios; Dezsoe Koermendy; Stefan Stortecky; Thomas Pilgrim; Lutz Buellesfeld; Peter Wenaweser; Stephan Windecker; Aris Moschovitis; Milosz Jaguszewski; Ulf Landmesser; Fabian Nietlispach; Bernhard Meier
Journal:  Clin Res Cardiol       Date:  2015-03-04       Impact factor: 5.460

Review 4.  Stroke prevention in atrial fibrillation: atrial appendage closure.

Authors:  Cindy J Fuller; Mark Reisman
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

5.  Uncommon delayed and late complications after percutaneous left atrial appendage closure with Amplatzer(®) Cardiac Plug.

Authors:  Marco R Schroeter; Bernhard C Danner; Mark Hünlich; Wolfgang Schillinger
Journal:  Clin Res Cardiol       Date:  2013-12-06       Impact factor: 5.460

Review 6.  Modern treatment of atrial fibrillation.

Authors:  Kyung-Hwan Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-12-05

7.  The healing response of LAMax LAAC™ left atrial appendage occluder in a canine model: the potential influence of the implantation technique on the healing response.

Authors:  Xiaoxia Wu; Dongxing Ma; Tao Wan; Yuezhi Meng; Yilong Chen; Yejia Shen; Wei Huang
Journal:  BMC Cardiovasc Disord       Date:  2022-06-27       Impact factor: 2.174

8.  Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies.

Authors:  José María Bastida; María Teresa Cano-Mozo; Felix Lopez-Cadenas; Victor Eduardo Vallejo; Soraya Merchán; Cecilia Santos-Montón; David González-Calle; Javier Carrillo; Ana Africa Martín; Jose Angel Torres-Hernández; Marcos González; Francisco Martín-Herrero; Pedro Pabón; Jose Ramon González-Porras
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.